MX2019010487A - Derivado de amina ciclica y uso farmaceutico del mismo. - Google Patents
Derivado de amina ciclica y uso farmaceutico del mismo.Info
- Publication number
- MX2019010487A MX2019010487A MX2019010487A MX2019010487A MX2019010487A MX 2019010487 A MX2019010487 A MX 2019010487A MX 2019010487 A MX2019010487 A MX 2019010487A MX 2019010487 A MX2019010487 A MX 2019010487A MX 2019010487 A MX2019010487 A MX 2019010487A
- Authority
- MX
- Mexico
- Prior art keywords
- amine derivative
- cyclic amine
- pharmaceutical use
- present
- pain
- Prior art date
Links
- -1 Cyclic amine Chemical class 0.000 title abstract 2
- 208000001640 Fibromyalgia Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La presente invención se refiere a un compuesto que ejerce un fuerte efecto analgésico contra el dolor, en particular, dolor neuropático y/o síndrome de fibromialgia. La presente invención proporciona un derivado de amina cíclica representado por la siguiente fórmula general, un profármaco del mismo o una sal del mismo farmacológicamente aceptable. Fórmula 1 (ver Fórmula).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013199853 | 2013-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019010487A true MX2019010487A (es) | 2019-10-17 |
Family
ID=52743529
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016003432A MX371281B (es) | 2013-09-26 | 2014-09-26 | Derivado de amina ciclica y uso farmaceutico del mismo. |
MX2019010487A MX2019010487A (es) | 2013-09-26 | 2016-03-16 | Derivado de amina ciclica y uso farmaceutico del mismo. |
MX2019010485A MX2019010485A (es) | 2013-09-26 | 2016-03-16 | Derivado de amina ciclica y uso farmaceutico del mismo. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016003432A MX371281B (es) | 2013-09-26 | 2014-09-26 | Derivado de amina ciclica y uso farmaceutico del mismo. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019010485A MX2019010485A (es) | 2013-09-26 | 2016-03-16 | Derivado de amina ciclica y uso farmaceutico del mismo. |
Country Status (17)
Country | Link |
---|---|
US (1) | US9505740B2 (es) |
EP (3) | EP3511003B1 (es) |
JP (1) | JP6409573B2 (es) |
KR (1) | KR102276072B1 (es) |
CN (1) | CN105555778B (es) |
AU (1) | AU2014325146B2 (es) |
BR (1) | BR112016006258B1 (es) |
CA (1) | CA2924789C (es) |
DK (1) | DK3050877T3 (es) |
ES (3) | ES2869136T3 (es) |
HU (1) | HUE046485T2 (es) |
MX (3) | MX371281B (es) |
PL (1) | PL3050877T3 (es) |
PT (1) | PT3050877T (es) |
RU (1) | RU2638549C2 (es) |
TW (1) | TWI652264B (es) |
WO (1) | WO2015046403A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2667062C1 (ru) * | 2015-02-27 | 2018-09-14 | Торэй Индастриз, Инк. | Производное циклического амина и его фармацевтическое применение |
WO2016152952A1 (ja) * | 2015-03-24 | 2016-09-29 | 東レ株式会社 | 環状アミン誘導体及びその医薬用途 |
CA2980259C (en) * | 2015-03-24 | 2024-02-06 | Toray Industries, Inc. | Cyclic amine derivative and pharmaceutical use thereof |
DK3505515T3 (da) * | 2016-08-26 | 2022-01-24 | Toray Industries | Krystaller af cyklisk aminderivat og farmaceutisk anvendelse deraf |
MX2019010967A (es) * | 2017-03-31 | 2020-01-15 | Toray Industries | Agente terapeutico o profilactico para neuropatias perifericas. |
WO2021172488A1 (ja) * | 2020-02-28 | 2021-09-02 | 東レ株式会社 | 環状アミン誘導体及びその医薬用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2163150B (en) | 1984-07-19 | 1988-05-25 | Sandoz Ltd | 3-aminopropoxyaryl derivatives |
JP2567885Y2 (ja) | 1991-03-15 | 1998-04-08 | ソニー株式会社 | ビデオモニタ装置 |
GB0017256D0 (en) * | 2000-07-13 | 2000-08-30 | Merck Sharp & Dohme | Therapeutic agents |
WO2003031432A1 (en) | 2001-10-12 | 2003-04-17 | Novo Nordisk A/S | Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor |
EP1438304B1 (en) * | 2001-10-15 | 2006-12-06 | Janssen Pharmaceutica N.V. | Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
US7026312B2 (en) * | 2002-03-14 | 2006-04-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
MXPA05008878A (es) * | 2003-02-21 | 2005-10-05 | Pfizer | Derivados de aminotiazol sustituidos con cicloalquilo que contiene n y composiciones farmaceuticas para inhibir la proliferacion celular, y metodos para su uso. |
AU2004253245B2 (en) * | 2003-06-17 | 2010-02-11 | F. Hoffmann-La Roche Ag | CIS-imidazolines as MDM2 inhibitors |
US20050009841A1 (en) * | 2003-07-11 | 2005-01-13 | Zheng Guo Zhu | Novel amides useful for treating pain |
JP2006008664A (ja) | 2004-05-21 | 2006-01-12 | Takeda Chem Ind Ltd | イミダゾール誘導体、その製造法及び用途 |
WO2008077089A1 (en) | 2006-12-19 | 2008-06-26 | Smithkline Beecham Corporation | Pyrrolidinanilines |
WO2009158587A1 (en) * | 2008-06-26 | 2009-12-30 | Inspire Pharmaceuticals, Inc. | Method for treating pulmonary diseases using rho kinase inhibitor compounds |
WO2013147160A1 (ja) | 2012-03-29 | 2013-10-03 | 東レ株式会社 | 環状アミン誘導体及びその医薬用途 |
-
2014
- 2014-09-25 TW TW103133137A patent/TWI652264B/zh active
- 2014-09-26 BR BR112016006258-2A patent/BR112016006258B1/pt active IP Right Grant
- 2014-09-26 RU RU2016116036A patent/RU2638549C2/ru active
- 2014-09-26 EP EP19160339.8A patent/EP3511003B1/en active Active
- 2014-09-26 CN CN201480052613.8A patent/CN105555778B/zh active Active
- 2014-09-26 CA CA2924789A patent/CA2924789C/en active Active
- 2014-09-26 EP EP19160334.9A patent/EP3511002B1/en active Active
- 2014-09-26 MX MX2016003432A patent/MX371281B/es active IP Right Grant
- 2014-09-26 JP JP2014547208A patent/JP6409573B2/ja active Active
- 2014-09-26 WO PCT/JP2014/075569 patent/WO2015046403A1/ja active Application Filing
- 2014-09-26 ES ES19160339T patent/ES2869136T3/es active Active
- 2014-09-26 AU AU2014325146A patent/AU2014325146B2/en active Active
- 2014-09-26 KR KR1020167004551A patent/KR102276072B1/ko active IP Right Grant
- 2014-09-26 US US15/024,185 patent/US9505740B2/en active Active
- 2014-09-26 ES ES19160334T patent/ES2829286T3/es active Active
- 2014-09-26 ES ES14849588T patent/ES2759236T3/es active Active
- 2014-09-26 EP EP14849588.0A patent/EP3050877B1/en active Active
- 2014-09-26 DK DK14849588.0T patent/DK3050877T3/da active
- 2014-09-26 PT PT148495880T patent/PT3050877T/pt unknown
- 2014-09-26 HU HUE14849588A patent/HUE046485T2/hu unknown
- 2014-09-26 PL PL14849588T patent/PL3050877T3/pl unknown
-
2016
- 2016-03-16 MX MX2019010487A patent/MX2019010487A/es active IP Right Grant
- 2016-03-16 MX MX2019010485A patent/MX2019010485A/es active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501297A1 (en) | Cyclic amine derivative and pharmaceutical use thereof | |
MX2019010485A (es) | Derivado de amina ciclica y uso farmaceutico del mismo. | |
PH12016500467B1 (en) | Aminoheteroarlyl benzamides as kinase inhibitors | |
PH12015501993B1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
PH12015502031A1 (en) | Tetrahydropyrrolothiazine compounds | |
MX2017002028A (es) | Compuestos de pirrolopirimidina usados como agonista del receptor de tipo toll 7 (tlr7). | |
SA515360469B1 (ar) | مركبات حلقية غير متجانسة لتثبيط إنزيم جلوتاميناز والطرق الخاصة باستخدامها | |
SG10201804026WA (en) | Inhibitors of influenza viruses replication | |
MX2016002794A (es) | Compuestos antiproliferativos. | |
NZ729037A (en) | Carboxylic acid compound, method for preparation thereof, and use thereof | |
EA201492287A1 (ru) | Дейтерированные производные руксолитиниба | |
EA201500931A1 (ru) | Производные пиридин-4-ила | |
EA201690894A1 (ru) | Феноксиэтилы | |
EA201592268A1 (ru) | Дигидропиридиноновые ингибиторы mgat2 | |
PH12015502032A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
MX2016005287A (es) | Metodos para el tratamiento de distrofias musculares. | |
UA118008C2 (uk) | Спосіб синтезу (2е)-3-(3,4-диметоксифеніл)проп-2-еннітрилу та застосування в синтезі івабрадину та його адитивних солей з фармацевтично прийнятною кислотою | |
EA201690908A1 (ru) | Пиразолопиримидиновые соединения | |
MX2017011129A (es) | Derivado de amina ciclica y uso farmaceutico del mismo. | |
EA201690593A1 (ru) | Новые соединения мочевины | |
IN2014DE01203A (es) | ||
MX2017011120A (es) | Derivado de amina ciclica y uso farmaceutico del mismo. | |
EA201300281A3 (ru) | Новый способ синтеза ивабрадина и его аддиктивных солей с фармацевтически приемлемой кислотой | |
UA117655C2 (uk) | Спосіб синтезу 3-(2-бромо-4,5-диметоксифеніл)пропаннітрілу та застосування в синтезі івабрадину та його адитивних солей з фармацевтично прийнятною кислотою | |
MX345518B (es) | Compuestos analgesicos, metodos, y formulaciones. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |